Bronchogenic carcinoma in lung transplant recipients

J Heart Lung Transplant. 2001 Aug;20(8):908-11. doi: 10.1016/s1053-2498(01)00271-6.


Although lung transplant recipients have a higher prevalence of non-melanoma skin cancers and lymphoma than the general population, the same has not been noted for bronchogenic carcinoma. If an increased prevalence of bronchogenic carcinoma exists, contributing factors may include the high rate of previous tobacco use in this population and/or the chronic immunosuppression used to prevent allograft rejection. With time, the incidence of bronchogenic carcinoma in the lung transplant population is likely to parallel the increasing longevity and number of transplanted individuals. We describe 2 cases of bronchogenic carcinoma in lung transplant recipients that demonstrate the morbidity associated with the discovery or development of bronchogenic carcinoma in this population.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / pathology*
  • Adenocarcinoma / surgery
  • Carcinoma, Bronchogenic / pathology*
  • Carcinoma, Bronchogenic / surgery
  • Carcinoma, Squamous Cell / pathology*
  • Carcinoma, Squamous Cell / surgery
  • Female
  • Humans
  • Lung / pathology
  • Lung Neoplasms / pathology*
  • Lung Neoplasms / surgery
  • Lung Transplantation / pathology*
  • Lymph Node Excision
  • Lymphatic Metastasis
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local / pathology
  • Neoplasm Recurrence, Local / surgery
  • Neoplasm Staging
  • Pneumonectomy
  • Postoperative Complications / pathology*
  • Postoperative Complications / surgery
  • Reoperation